New study aims to reduce anti-rejection drugs after liver transplant

NCT ID NCT06280950

First seen May 15, 2026 · Last updated May 16, 2026 · Updated 1 time

Summary

This study tests whether liver transplant recipients can safely stop taking one anti-rejection medicine (tacrolimus) and use only everolimus to protect their kidneys. About 340 adults who received their first liver transplant will join. The goal is to see if this approach keeps the liver healthy while improving kidney function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor Medical Center (Site #: 71153)

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact Email: •••••@•••••

    Contact

  • Duke University Medical Center (Site #: 71139)

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Icahn School of Medicine at Mount Sinai (Site #: 71115)

    RECRUITING

    New York, New York, 10029, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Mayo Clinic Hospital Arizona (Site #: 71144)

    RECRUITING

    Phoenix, Arizona, 85054, United States

    Contact

    Contact Email: •••••@•••••

  • Northwestern University (Site #: 71110)

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California, San Francisco (Site #: 71108)

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Pennsylvania (Site #: 71111)

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pittsburgh Medical Center (Site #: 71170)

    RECRUITING

    Pittsburgh, Pennsylvania, 15260, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.